Indrayani Biotech Limited (BOM:526445)

Indrayani Biotech Revenue

Indrayani Biotech had revenue of 350.15M INR in the quarter ending December 31, 2025, with 102.18% growth. This brings the company's revenue in the last twelve months to 1.51B, up 21.44% year-over-year. In the fiscal year ending March 31, 2025, Indrayani Biotech had annual revenue of 1.30B, down -21.66%.

• Revenue (ttm): 1.51B
• Revenue Growth: +21.44%
• P/S Ratio: 0.31
• Revenue / Employee: 1.61M
• Employees: 936
• Market Cap: 469.02M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	1.30B	-359.97M	-21.66%
Mar 31, 2024	1.66B	32.96M	2.02%
Mar 31, 2023	1.63B	1.01B	164.57%
Mar 31, 2022	615.82M	403.91M	190.60%
Mar 31, 2021	211.91M	-287.06M	-57.53%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 27, 2026

Data Sources Report a data error